ArticleInternational journal of clinical oncology2015

Development of hypertension within 2 weeks of initiation of sorafenib for advanced hepatocellular carcinoma is a predictor of efficacy.

Noriyuki Akutsu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.